Medical Health Cluster

Patients

Air Trapping: Common in Patients With Long COVID

Small airway disease with air trapping appears to be a long-lasting sequela of SARS-CoV-2 infection, according to a prospective study that compared 100 COVID-19 survivors who had persistent symptoms and 106 healthy control persons. “Something is going on in the distal airways related to either inflammation or fibrosis that is […]

Read More

Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19

Question  Among patients at risk of disease progression, does early treatment of mild to moderate COVID-19 with the neutralizing antibody sotrovimab prevent progression to severe disease? Findings  In this randomized clinical trial of 1057 participants, treatment with a single intravenous dose of sotrovimab, compared with placebo, resulted in a statistically significant reduction […]

Read More

One Size Doesn’t Fit All: COVID-19 Vaccines and Immunocompromised Patients

INTERVIEW BY STEPHANIE DESMON For many immunocompromised patients, the regular two-dose COVID-19 vaccine regimen—and in some cases, even a third dose—didn’t provide sufficient immune protection. As a result, approximately 5 to 7 million immunocompromised people living in the U.S. have been struggling for over a year with how they will […]

Read More

Patients With Greatest Odds of Surviving COVID-19 Should Get First Dibs on Scarce ICU Beds: Survey

A new survey finds most Americans are in favor of allotting “the last ICU bed” to the patient with the highest probability of surviving COVID-19. Responses from 2,000 respondents from the nationally representative YouGov internet panel also show that, for the most part, people were not swayed by the age […]

Read More

The COVID-19 Treatment Guidelines Panel’s Statement on Therapies for High-Risk, Nonhospitalized Patients With Mild to Moderate COVID-19

The following statement is an updated version of the statement that the COVID-19 Treatment Guidelines Panel (the Panel) released on December 30, 2021. This update addresses the fact that the B.1.1.529 (Omicron) variant of concern (VOC) is now the dominant SARS-CoV-2 variant in all 10 of the Department of Health and […]

Read More

Posthospitalization VTE Prophylaxis for Some Patients with COVID-19

Low-dose rivaroxaban at discharge prevented some venous thromboembolism events at 1 month for high-risk patients. Therapeutic anticoagulation after hospital discharge does not benefit moderate-risk patients recovering from COVID-19 (NEJM JW Gen Med Aug 1 2021 and Lancet 2021; 397:2253), but whether high-risk patients might benefit is unclear. Brazilian investigators enrolled 320 patients (from […]

Read More

Measuring Viral RNA Can Identify COVID-19 Patients Most at Risk of Dying

The amount of a SARS-CoV-2 genetic material—viral RNA—in the blood is a reliable indicator in detecting which patients will die of the disease, a team led by Université de Montréal medical professor Dr. Daniel Kaufmann has found. The finding is published today in Science Advances. Kaufmann and his team did the work at […]

Read More

Doctors Facing Aggression From Patients Who Refuse to Wear Masks

Doctors in Northern Ireland have reported facing increasing cases of aggression from patients and hospital visitors refusing to wear face masks during NHS appointments. The British Medical Association said there was also growing resistance to being tested for COVID before attending routine appointments or going to emergency departments. Dr David Farren, deputy chair of […]

Read More